Xin Wang v. Injective Labs Inc. and Zhonghan “Eric” Chen

Summary

The United States District Court for the District of Delaware denied Xin Wang’s motion to bifurcate the upcoming jury trial into separate liability and damages phases under Federal Rule of Civil Procedure 42(b). The court concluded that bifurcation would not materially reduce complexity, confusion, time, or expense, and that Wang had not shown sufficient convenience or economy to justify departing from the usual single-phase trial procedure.

Holdings

1. The motion to bifurcate the trial was denied because Wang failed to establish that separate liability and damages proceedings would provide greater convenience, expedite the case, promote economy, or avoid undue prejudice.

Questions Presented

1. Whether the district court should bifurcate the jury trial into separate liability and damages phases under Federal Rule of Civil Procedure 42(b).
2. Whether the asserted complexity of the agreements, liability issues, and damages calculations established that bifurcation would promote convenience, expedition, or economy or prevent undue prejudice.

Disposition

other